drugset

drugset / Trial / NCT01860781

The Effect of Paliperidone Palmitate in Schizophrenia

NCT01860781 ↗

Phase 4 Completed 30 enrolled Seoul National University Hospital

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is the evaluation of effectiveness of paliperidone palmitate within three different group of schizophrenia patients.

Timeline

Start: 2011-08
Primary completion: 2015-12
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	paliperidone palmitate	Unknown	75 mg	—

Indications